美股财报 | 坎伯兰药业发布Q2财报前半年累计净利润51.30万美元

同花顺iNews2025-08-09

坎伯兰药业(CPIX)发布Q2财报，2025财年前六月累计收入2255.04万美元，去年同期累计收入为1834.66万美元，同比增长22.91%。2025财年前六月累计净利润51.30万美元，去年同期累计净亏损为300.51万美元。本财年累计基本每股收益为0.03美元，去年同期为-0.21美元。公司所属行业为制药。【公司信息】Cumberland Pharmaceuticals Inc.于1999...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2558501196?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-08-09 18:00","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2558501196","market":"us","top_or_hot":-1,"title":"美股财报 | 坎伯兰药业发布Q2财报 前半年累计净利润51.30万美元","media":"同花顺iNews","content":"<div>\n<p>坎伯兰药业(CPIX)发布Q2财报，2025财年前六月累计收入2255.04万美元，去年同期累计收入为1834.66万美元，同比增长22.91%。2025财年前六月累计净利润51.30万美元，去年同期累计净亏损为300.51万美元。本财年累计基本每股收益为0.03美元，去年同期为-0.21美元。公司所属行业为制药。【公司信息】Cumberland Pharmaceuticals Inc.于1999...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250809180541a6dc5e88&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>美股财报 | 坎伯兰药业发布Q2财报 前半年累计净利润51.30万美元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n美股财报 | 坎伯兰药业发布Q2财报 前半年累计净利润51.30万美元\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-08-09 18:00 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250809180541a6dc5e88&s=b><strong>同花顺iNews</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>坎伯兰药业(CPIX)发布Q2财报，2025财年前六月累计收入2255.04万美元，去年同期累计收入为1834.66万美元，同比增长22.91%。2025财年前六月累计净利润51.30万美元，去年同期累计净亏损为300.51万美元。本财年累计基本每股收益为0.03美元，去年同期为-0.21美元。公司所属行业为制药。【公司信息】Cumberland Pharmaceuticals Inc.于1999...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250809180541a6dc5e88&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"CPIX","symbol_name":"坎伯兰药业","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250809180541a6dc5e88&s=b","article_id":"2558501196","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250809180541a6dc5e88&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2558501196","pubTimestamp":1754733612,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"坎伯兰药业发布Q2财报，2025财年前六月累计收入2255.04万美元，去年同期累计收入为1834.66万美元，同比增长22.91%。2025财年前六月累计净利润51.30万美元，去年同期累计净亏损为300.51万美元。该公司的业务开发团队识别，评估及谈判产品收购，进口许可和出口许可的机会。该公司的产品开发团队开发专有产品配方，管理其临床试验，准备所有的监管意见书及管理其医疗呼叫中心。该公司的高品质的和专业制造人士监督其产品的生产。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":["earning"],"viewcount":null,"language":"zh","relate_stocks":{"CPIX":"坎伯兰药业"},"translate_title":"U.S. Stock Financial Report | Cumberland Pharmaceuticals releases Q2 financial report, cumulative net profit in the first half of the year is US $513,000","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CPIX":1},"content_text":"坎伯兰药业(CPIX)发布Q2财报，2025财年前六月累计收入2255.04万美元，去年同期累计收入为1834.66万美元，同比增长22.91%。2025财年前六月累计净利润51.30万美元，去年同期累计净亏损为300.51万美元。本财年累计基本每股收益为0.03美元，去年同期为-0.21美元。公司所属行业为制药。【公司信息】Cumberland Pharmaceuticals Inc.于1999年注册成立。专注于品牌处方产品的收购、开发和商业化，是一家不断发展的专业制药公司。该公司的主要目标市场是医院的急症护理和胃肠病，其特征是该公司认为可以有效地通过相对小，针对性的销售力量渗透相对集中的医师开具处方基地。该公司致力于提供能够为患者提高护理质量和解决很难达到的医疗要求的创新产品。公司拥有产品开发和商业能力，并相信可以利用其现有的基础设施，以支持其预期的增长。公司的管理团队由医药行业资深人士组成。其在业务发展，产品开发，商业和金融方面经历丰富。该公司的业务开发团队识别，评估及谈判产品收购，进口许可和出口许可的机会。该公司的产品开发团队开发专有产品配方，管理其临床试验，准备所有的监管意见书及管理其医疗呼叫中心。该公司的高品质的和专业制造人士监督其产品的生产。该公司的市场营销和销售的专业人士负责其商业活动，而该公司与第三方分销合作伙伴密切合作，以确保可用性和交付其产品。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"dataReport","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2558501196","isCrawlerRequest":true}

美股财报 | 坎伯兰药业发布Q2财报 前半年累计净利润51.30万美元

精彩评论

美股财报 | 坎伯兰药业发布Q2财报前半年累计净利润51.30万美元